194 results on '"Chowdhary, Saqib"'
Search Results
2. Coronary and Systemic Vasodilator Responsiveness of Patients Receiving Conventional Intermittent or Nocturnal Hemodialysis.
3. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI
4. OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
5. TCT-670 Suboptimal OCT Guiding and Association With 2-Year Clinical Outcomes: An OCTOBER Trial Substudy
6. Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial
7. 56 One year survival rates in out-of-hospital cardiac arrest survivors undergoing percutaneous coronary intervention post myocardial infarction in a single UK tertiary centre
8. Nitric oxide and human cardiac vagal control
9. One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial
10. OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
11. A contemporary risk model for predicting 30-day mortality following percutaneous coronary intervention in England and Wales
12. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial
13. MitraClip Therapy for Functional Mitral Regurgitation: Importance of Jet Localization to Direct MitraClip Placement
14. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
15. Prognostic Role of Residual Thrombus Burden Following Thrombectomy: Insights From the TOTAL Trial
16. Bioabsorbable Polymer-Coated Sirolimus-Eluting Stent Implantation Preserves Coronary Vasomotion: A DESSOLVE II Trial Sub-study
17. TCT-189 Effect of Low-Dose Intracoronary Alteplase on Global Circumferential Strain: Myocardial Strain Cardiovascular Magnetic Resonance Substudy of the T-TIME Trial
18. Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy
19. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial
20. The Toronto score for in-hospital mortality after percutaneous coronary interventions
21. Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial
22. MitraClip Therapy for Functional Mitral Regurgitation: Importance of Jet Localization to Direct MitraClip Placement
23. Effects of nitroglycerin treatment on cardiac autonomic control in heart failure
24. GABAergic mechanisms involved in the vagally mediated heart rate response to muscle contraction as revealed by studies with benzodiazepines
25. Standalone Balloon Aortic Valvuloplasty: Indications and Outcomes From the UK in the Transcatheter Valve Era
26. Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction: The INFUSE-AMI Randomized Trial
27. Assessing healing of drug eluting stents
28. Low-dose intracoronary alteplase during primary percutaneous coronary intervention in patients with acute myocardial infarction: the T-TIME three-arm RCT
29. TCT CONNECT-16 Implications of Impaired Coronary Flow on the Effects of Intracoronary Alteplase During Primary Percutaneous Coronary Intervention
30. TCT CONNECT-28 Left Ventricular End-Diastolic Pressure in Acute Myocardial Infarction, Association With Infarct Pathology, Left Ventricular Function, and Health Outcomes
31. A detailed analysis of patients included in the Summary Hospital-level Mortality Indicator (SHMI) for myocardial infarction (MI)—all is not what it seems?
32. Inferior Infarction Following Alcohol Septal Ablation: a Consequence of “Collateral Damage”?
33. Acute aldosterone antagonism improves cardiac vagal control in humans
34. Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment
35. Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial
36. Initial experience of a self‐expanding transcatheter aortic valve with an outer pericardial wrap: The United Kingdom and Ireland Implanters' registry
37. Impact of established cardiovascular disease on outcomes in the randomized global leaders trial.
38. Initial experience of a self‐expanding transcatheter aortic valve with an outer pericardial wrap: The United Kingdom and Ireland Implanters' registry.
39. Initial experience of a large, self‐expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters’ registry
40. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
41. Initial experience of a large, self‐expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry.
42. Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.
43. Myocardial blush and microvascular reperfusion following manual thrombectomy during percutaneous coronary intervention for ST elevation myocardial infarction: insights from the TOTAL trial
44. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies:a report from the international working group for intravascular optical coherence tomography standardization and validation
45. Does the CHA2DS2-Vasc score predict procedural and short-term outcomes in patients undergoing transcatheter aortic valve implantation?
46. Multiparametric Cardiovascular Magnetic Resonance Assessment of Cardiac Allograft Vasculopathy
47. Optical Coherence Tomography Appearances in Healed Coronary Artery Aneurysms After Stent Implantation
48. Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI
49. Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
50. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vsaspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.